(Q40582104)

21 September 2017

title

Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line (English)

1 reference

21 September 2017

1 reference

1 reference

1 reference

6

Daniel Louvard

1 reference

21 September 2017

8

Sylvie Robine

1 reference

21 September 2017

Miguel Abal

1

1 reference

21 September 2017

Rui Bras-Goncalves

2

1 reference

21 September 2017

Jean-Gabriel Judde

3

1 reference

21 September 2017

Hafida Fsihi

4

1 reference

21 September 2017

Patricia De Cremoux

5

1 reference

21 September 2017

Henri Magdelenat

7

1 reference

21 September 2017

Marie-France Poupon

9

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

9

1 reference

21 September 2017

page(s)

1737-1744

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207299

21 September 2017

exact match

0 references

cites work

Advances in the treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

Molecular biology of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

Review of the role of CPT-11 in the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

Irinotecan in the treatment of colorectal cancer: clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

Camptothecin inhibits both the cleavage and religation reactions of eukaryotic DNA topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

Molecular interactions in the Vogelstein model of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

p53 mutation as a genetic trait of typical medullary breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

RETRACTED: Regulation of p53: intricate loops and delicate balances

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

New directions in the treatment of colorectal cancer: a look to the future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Regulation of the G2/M transition by p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

P53 status plays no role in radiosensitizing effects of SN-38, a camptothecin derivative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207299

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207299

1 reference

Dimensions Publication ID

21 September 2017

1027164891

0 references

1 reference